Japan: Examining the first biosimilar patent litigation

In Japan, effectiveness and efficacy have been observed in breast cancer where overexpression of HER 2 was seen and in unresectable advanced or recurrent gastric cancer where overexpression of HER 2 w…
( read original story …)


Related Post

Japan Post considers multi-billion dollar Toll Gro...
views 283
Those failings, say brokers, have been reflected i...
Japan to scrap sister-city relationship with San F...
views 222
TOKYO—Japan expressed strong regret Friday over Sa...
Adnoc boosts ties with Japan
views 188
and the Japan Oil, Gas and Metals National Company...
Japan’s Banks Tap a Gold Mine
views 198
Japan's banks are in a difficult place. While the ...
Mascot designs for 2020 Tokyo Olympics shortlisted
views 204
TOKYO (AP) — Japanese schoolchildren will help det...
Nikkei rises as Wall Street keeps climbing, but st...
views 248
TOKYO, Dec 8 (Reuters) - Japan's Nikkei share aver...
How Wisconsin Lured Foxconn’s Massive Manufa...
views 264
This will be the first factory of its kind in the ...
The new wave of Japanese investment is in your nei...
views 66
One explanation for why there may be much more Jap...
Banking reform in China: Too little, too late?
views 284
Japan, and the European Union, but to do so, it mu...
Tokyo Olympics: Eight more sports added for 2020
views 263
The additions, starting with the 2020 Games in Tok...